Pharmaceuticals, Biotechnology and Life Sciences
Study published in the Journal of Clinical PsychopharmacologySALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:…
Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) — Boston Hemp Inc., a leader in compliant hemp-derived cannabis, today announced…
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases,…
WEST PALM BEACH, FL, April 16, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”) announces that it has filed…
CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and…
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild…
SANTA BARBARA, Calif., April 15, 2025 (GLOBE NEWSWIRE) — Raw Garden, the leader in clean and green California cannabis, is…
MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company)…
MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company,…
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) — Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing…